中药干预下晚期非小细胞肺癌患者生存时间的回顾性分析

《中药干预下晚期非小细胞肺癌患者生存时间的回顾性分析》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、目录摘要·································································································1前言·································································································41对象与方法·····················································

2、······························61.1研究对象······················································································61.2研究方法·····················································································61.3观察项目·····································

3、·················································61.4中药剂型及使用方法·······································································81.5临床资料分析················································································81.6随访·································

4、···························································91.7统计方法······················································································92结果····························································································103理论探讨······

5、················································································133.1中医对肺癌的认识········································································133.2现代医学对肺癌的认识··································································143.3中晚期肺小细胞肺癌临床

6、研究进展···················································153.4高龄晚期非小细胞肺癌的治疗现状···················································153.2导师学术思想探讨········································································163.5本研究分析及与国内外同类研究的比较·····························

7、················174结论····························································································19参考文献·························································································20致谢··················································

8、·············································22附录1····························································································23附录2···················